<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">24721208</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>07</Month>
            <Day>25</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5875</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>53</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The international journal of biochemistry &amp; cell biology</Title>
                <ISOAbbreviation>Int. J. Biochem. Cell Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>475-81</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biocel.2014.03.027</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S1357-2725(14)00110-1</ELocationID>
            <Abstract>
                <AbstractText>Benign fibrous histiocytoma (BFH) is a mesenchymal tumor that most often occurs in the skin (so-called dermatofibroma), but may also appear in soft tissues (so-called deep BFH) and in the skeleton (so-called non-ossifying fibroma). The origin of BFH is unknown, and it has been questioned whether it is a true neoplasm. Chromosome banding, fluorescence in situ hybridization, single nucleotide polymorphism arrays, RNA sequencing, RT-PCR and quantitative real-time PCR were used to search for recurrent somatic mutations in a series of BFH. BFHs were found to harbor recurrent fusions of genes encoding membrane-associated proteins (podoplanin, CD63 and LAMTOR1) with genes encoding protein kinase C (PKC) isoforms PRKCB and PRKCD. PKCs are serine-threonine kinases that through their many phosphorylation targets are implicated in a variety of cellular processes, as well as tumor development. When inactive, the amino-terminal, regulatory domain of PKCs suppresses the activity of their catalytic domain. Upon activation, which requires several steps, they typically translocate to cell membranes, where they interact with different signaling pathways. The detected PDPN-PRKCB, CD63-PRKCD and LAMTOR1-PRKCD gene fusions are all predicted to result in chimeric proteins consisting of the membrane-binding part of PDPN, CD63 or LAMTOR1 and the entire catalytic domain of the PKC. This novel pathogenetic mechanism should result in constitutive kinase activity at an ectopic location. The results show that BFH indeed is a true neoplasm, and that distorted PKC activity is essential for tumorigenesis. The findings also provide means to differentiate BFH from other skin and soft tissue tumors. This article is part of a Directed Issue entitled: Rare cancers.</AbstractText>
                <CopyrightInformation>Copyright ¬© 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>P?Çaszczyca</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nilsson</LastName>
                    <ForeName>Jenny</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Magnusson</LastName>
                    <ForeName>Linda</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brosj√∂</LastName>
                    <ForeName>Otte</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Department of Orthopedics, Karolinska University Hospital, SE-171 76 Solna, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Larsson</LastName>
                    <ForeName>Olle</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Department of Pathology, Karolinska University Hospital, SE-171 76 Solna, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vult von Steyern</LastName>
                    <ForeName>Fredrik</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Orthopedics, Sk√•ne University Hospital, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Domanski</LastName>
                    <ForeName>Henryk A</ForeName>
                    <Initials>HA</Initials>
                    <Affiliation>Department of Pathology, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lilljebj√∂rn</LastName>
                    <ForeName>Henrik</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fioretos</LastName>
                    <ForeName>Thoas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tayebwa</LastName>
                    <ForeName>Johnbosco</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mandahl</LastName>
                    <ForeName>Nils</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nord</LastName>
                    <ForeName>Karolin H</ForeName>
                    <Initials>KH</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mertens</LastName>
                    <ForeName>Fredrik</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Clinical Genetics, University and Regional Laboratories, Lund University, SE-221 85 Lund, Sweden. Electronic address: fredrik.mertens@med.lu.se.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>04</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Int J Biochem Cell Biol</MedlineTA>
            <NlmUniqueID>9508482</NlmUniqueID>
            <ISSNLinking>1357-2725</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CD63</Keyword>
            <Keyword MajorTopicYN="N">Cell membrane</Keyword>
            <Keyword MajorTopicYN="N">Endosomes</Keyword>
            <Keyword MajorTopicYN="N">Gene fusion</Keyword>
            <Keyword MajorTopicYN="N">LAMTOR1</Keyword>
            <Keyword MajorTopicYN="N">Podoplanin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24721208</ArticleId>
            <ArticleId IdType="pii">S1357-2725(14)00110-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biocel.2014.03.027</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
